- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Right Turn Show - Optimal Use of Dapagliflozin and its Combinations in Specialty Care Settings - Video
Overview
Bringing you the 'Right Turn Show,' where we focus on the optimal use of dapagliflozin and its combinations in speciality care settings. In this episode, we have two distinguished experts Dr Johann Christopher, a Consultant Cardiologist at CARE Hospital, Hyderabad, and Dr Bipin Kumar Sethi, a renowned Endocrinologist at CARE Hospitals, Hyderabad.
With vast experience in their respective fields, Dr Christopher and Dr Sethi bring a comprehensive perspective on how they utilize dapagliflozin in their clinical practice.
Dapagliflozin is a popular choice among doctors for managing Type 2 Diabetes and also plays a crucial role in treating heart failure and chronic kidney disease (CKD).
In this episode, they share their insights on:
1) Cardio-renal-metabolic benefits of the use of dapagliflozin in T2DM patients as well as cardiology settings
2) Applicability of Dapagliflozin Sitagliptin dual combination in cardiology settings
3) After how many years do Indian T2DM patients fail to achieve glucose control with two agents & what are the considerations & need for triple agents in these patients?
4) Applicability of Dapagliflozin Sitagliptin Metformin triple combination in cardiology and Diabetes settings